119 related articles for article (PubMed ID: 29066722)
1. BCL-X
Carné Trécesson S; Souazé F; Basseville A; Bernard AC; Pécot J; Lopez J; Bessou M; Sarosiek KA; Letai A; Barillé-Nion S; Valo I; Coqueret O; Guette C; Campone M; Gautier F; Juin PP
Nat Commun; 2017 Oct; 8(1):1123. PubMed ID: 29066722
[TBL] [Abstract][Full Text] [Related]
2. Bcl-XL is qualitatively different from and ten times more effective than Bcl-2 when expressed in a breast cancer cell line.
Fiebig AA; Zhu W; Hollerbach C; Leber B; Andrews DW
BMC Cancer; 2006 Aug; 6():213. PubMed ID: 16928273
[TBL] [Abstract][Full Text] [Related]
3. Aven blocks DNA damage-induced apoptosis by stabilising Bcl-xL.
Kutuk O; Temel SG; Tolunay S; Basaga H
Eur J Cancer; 2010 Sep; 46(13):2494-505. PubMed ID: 20619636
[TBL] [Abstract][Full Text] [Related]
4. Reversal of Mutant KRAS-Mediated Apoptosis Resistance by Concurrent Noxa/Bik Induction and Bcl-2/Bcl-xL Antagonism in Colon Cancer Cells.
Okamoto K; Zaanan A; Kawakami H; Huang S; Sinicrope FA
Mol Cancer Res; 2015 Apr; 13(4):659-69. PubMed ID: 25548100
[TBL] [Abstract][Full Text] [Related]
5. BCL-X
Trisciuoglio D; Tupone MG; Desideri M; Di Martile M; Gabellini C; Buglioni S; Pallocca M; Alessandrini G; D'Aguanno S; Del Bufalo D
Cell Death Dis; 2017 Dec; 8(12):3216. PubMed ID: 29238043
[TBL] [Abstract][Full Text] [Related]
6. Differential effect of anti-apoptotic genes Bcl-xL and c-FLIP on sensitivity of MCF-7 breast cancer cells to paclitaxel and docetaxel.
Wang Z; Goulet R; Stanton KJ; Sadaria M; Nakshatri H
Anticancer Res; 2005; 25(3c):2367-79. PubMed ID: 16080463
[TBL] [Abstract][Full Text] [Related]
7. Apoptotic activity of 5-fluorouracil in breast cancer cells transformed by low doses of ionizing α-particle radiation.
Ponce-Cusi R; Calaf GM
Int J Oncol; 2016 Feb; 48(2):774-82. PubMed ID: 26691280
[TBL] [Abstract][Full Text] [Related]
8. Functional and biological analysis of Bcl-xL expression in human osteosarcoma.
Wang ZX; Yang JS; Pan X; Wang JR; Li J; Yin YM; De W
Bone; 2010 Aug; 47(2):445-54. PubMed ID: 20580954
[TBL] [Abstract][Full Text] [Related]
9. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients.
He M; Fu Y; Yan Y; Xiao Q; Wu H; Yao W; Zhao H; Zhao L; Jiang Q; Yu Z; Jin F; Mi X; Wang E; Cui Z; Fu L; Chen J; Wei M
Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092
[TBL] [Abstract][Full Text] [Related]
10. AT-101 simultaneously triggers apoptosis and a cytoprotective type of autophagy irrespective of expression levels and the subcellular localization of Bcl-xL and Bcl-2 in MCF7 cells.
Antonietti P; Gessler F; Düssmann H; Reimertz C; Mittelbronn M; Prehn JH; Kögel D
Biochim Biophys Acta; 2016 Apr; 1863(4):499-509. PubMed ID: 26721623
[TBL] [Abstract][Full Text] [Related]
11. Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL.
Hari Y; Harashima N; Tajima Y; Harada M
Oncotarget; 2015 Dec; 6(39):41902-15. PubMed ID: 26506422
[TBL] [Abstract][Full Text] [Related]
12. Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA-damaging agents.
Fan S; Wang JA; Yuan RQ; Rockwell S; Andres J; Zlatapolskiy A; Goldberg ID; Rosen EM
Oncogene; 1998 Jul; 17(2):131-41. PubMed ID: 9674697
[TBL] [Abstract][Full Text] [Related]
13. NF1 deficiency causes Bcl-xL upregulation in Schwann cells derived from neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
Park HJ; Lee SJ; Sohn YB; Jin HS; Han JH; Kim YB; Yim H; Jeong SY
Int J Oncol; 2013 Feb; 42(2):657-66. PubMed ID: 23292448
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of apoptosis-related bcl-2 but not bcl-xL or bax proteins in multidrug-resistant MCF-7/Adr human breast cancer cells.
Ogretmen B; Safa AR
Int J Cancer; 1996 Sep; 67(5):608-14. PubMed ID: 8782646
[TBL] [Abstract][Full Text] [Related]
15. Fish oil targets PTEN to regulate NFkappaB for downregulation of anti-apoptotic genes in breast tumor growth.
Ghosh-Choudhury T; Mandal CC; Woodruff K; St Clair P; Fernandes G; Choudhury GG; Ghosh-Choudhury N
Breast Cancer Res Treat; 2009 Nov; 118(1):213-28. PubMed ID: 18953692
[TBL] [Abstract][Full Text] [Related]
16. Bcl-xL promotes metastasis of breast cancer cells by induction of cytokines resistance.
Fernández Y; España L; Mañas S; Fabra A; Sierra A
Cell Death Differ; 2000 Apr; 7(4):350-9. PubMed ID: 10773819
[TBL] [Abstract][Full Text] [Related]
17. A signal network involving coactivated NF-kappaB and STAT3 and altered p53 modulates BAX/BCL-XL expression and promotes cell survival of head and neck squamous cell carcinomas.
Lee TL; Yeh J; Friedman J; Yan B; Yang X; Yeh NT; Van Waes C; Chen Z
Int J Cancer; 2008 May; 122(9):1987-98. PubMed ID: 18172861
[TBL] [Abstract][Full Text] [Related]
18. The proto-oncoprotein c-Fos negatively regulates hepatocellular tumorigenesis.
Mikula M; Gotzmann J; Fischer AN; Wolschek MF; Thallinger C; Schulte-Hermann R; Beug H; Mikulits W
Oncogene; 2003 Oct; 22(43):6725-38. PubMed ID: 14555986
[TBL] [Abstract][Full Text] [Related]
19. Chemosensitization of solid tumors by inhibition of Bcl-xL expression using DNAzyme.
Yu X; Yang L; Cairns MJ; Dass C; Saravolac E; Li X; Sun LQ
Oncotarget; 2014 Oct; 5(19):9039-48. PubMed ID: 25344863
[TBL] [Abstract][Full Text] [Related]
20. Bcl-xL is an oncogenic driver in colorectal cancer.
Scherr AL; Gdynia G; Salou M; Radhakrishnan P; Duglova K; Heller A; Keim S; Kautz N; Jassowicz A; Elssner C; He YW; Jaeger D; Heikenwalder M; Schneider M; Weber A; Roth W; Schulze-Bergkamen H; Koehler BC
Cell Death Dis; 2016 Aug; 7(8):e2342. PubMed ID: 27537525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
